The semaglutide market will be supported by rising diagnosis of type 2 diabetes requiring early-stage incretin therapy, strong clinical preference for twice-daily and once-weekly formulations among patients needing weight management assistance, growing adoption due to favorable glycemic control outcomes in overweight adults, increasing use in combination therapy for individuals with uncontrolled HbA1c levels, expanding access through reimbursement programs across developing regions and broader physician familiarity with long-established molecules in this class
The limited efficacy of current antidepressant therapies can be explained by the heterogeneity of depressive disorders
By using liposomal technology, we ensure that the sulfur-bearing cysteine reaches your cells intact
Sex-dependent association between inflammation, neural stress responses, and impaired myocardial function
and Frye, R
Verma S, Poulter NR, Bhatt DL, Bain SC, Buse JB, Leiter LA, et al